CVRx
-
Devices & Diagnostics, Startups
J&J’s venture arm backs CVRx in $93 million funding round
CVRx, which has struggled to get the FDA nod for an earlier generation device, will use the money to progress its pivotal clinical trial in the U.S. to treat patients with congestive heart failure using neuromodulation.
-
Streamline the Process for Consent Collection and Management
Join us on April 16th and hear executives from DocuSign and Velatura discuss how their partnership modernizes and facilitates the efficient and secure completion of the patient consent form.
-
Devices & Diagnostics, Health IT, Pharma, Startups
Don’t let the IPOs fool you. Healthcare deal activity and funding were down in Q3
Womp womp. Though Q3 saw 13 healthcare industry IPOs–a five-quarter high, the past quarter also […]
-
Devices & Diagnostics, Startups
Some bright news at the end of very dark tunnel: VC firm raises an oversubscribed round for late-stage medtech companies
Just when it looks like it’s time for the device industry to karaoke some Alanis […]
-
Minnesota hypertension treatment firm names new chief commercial officer
Privately held CVRx that has created an implantable device to treat high blood pressure announced […]